Implementation of Common Rule Changes to the Informed Consent Form: A Research Staff and Institutional Review Board Collaboration

被引:6
|
作者
Gartel, Grace [1 ]
Scuderi, Heather [2 ]
Servay, Christine [3 ]
机构
[1] Kayentis, Boston, MA USA
[2] Ochsner Clin Fdn, 1514 Jefferson Hwy, New Orleans, LA 70121 USA
[3] Ochsner Clin Fdn, Ochsner Clin Fdn Inst Review Board, New Orleans, LA USA
来源
OCHSNER JOURNAL | 2020年 / 20卷 / 01期
关键词
Consent forms; ethics committees-research; research personnel; research subjects;
D O I
10.31486/toj.19.0080
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The Common Rule, which governs federally funded clinical research involving human subjects, formally defines the requirements for institutional review board (IRB) membership, functions and operations, and review of research, as well as the requirements for obtaining informed consent from research participants. The revisions to the Common Rule effective in January 2019 changed some content requirements for informed consent forms. Methods: This article summarizes the history of informed consent requirements, the changes made to the requirements by the revision to the Common Rule, and the ways in which IRBs and research staff work together to develop informed consent forms that comply with the regulations and provide all the information potential research subjects need to decide whether to participate in a study. Results: Clinical research coordinators, under their investigators' supervision, are responsible for ensuring that research consent forms comply with the requirements of the federal regulations and the institution. Many IRBs have provided education regarding these new requirements, as well as consent templates that contain all the required elements. To ensure that the Common Rule's requirements are met, the IRB reviews each study submission, including the consent form. The IRB panel makes revisions to the consent forms as needed and returns the approved consent form to the investigator and clinical research coordinator. Conclusion: Research coordinators play an essential role in developing consent forms and providing the required review information to the IRB. In turn, through optimizing and standardizing consent forms and ensuring that all requirements of the Common Rule are followed, IRBs ensure that the rights of participants are protected and upheld.
引用
收藏
页码:76 / 80
页数:5
相关论文
共 49 条
  • [41] Changes in the institutional review board submission process for multicenter research over 6 years
    Pogorzelska, Monika
    Stone, Patricia W.
    Cohn, Elizabeth Gross
    Larson, Elaine
    NURSING OUTLOOK, 2010, 58 (04) : 181 - 187
  • [42] Comprehension and Choice Under the Revised Common Rule: Improving Informed Consent by Offering Reasons Why Some Enroll in Research and Others Do Not
    Kraft, Stephanie A.
    Porter, Kathryn M.
    Shah, Seema K.
    Wilfond, Benjamin S.
    AMERICAN JOURNAL OF BIOETHICS, 2017, 17 (07): : 53 - 55
  • [43] Reporting of informed consent and approval by institutional review board (IRB) in randomized controlled drug trials conducted in nursing homes (NH) from 1968 to 2004.
    Cheng, H.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2007, 55 (04) : S35 - S36
  • [44] Clinical Research From Proposal to Implementation: What Every Clinical Investigator Should Know About the Institutional Review Board
    Rivera, Suzanne M.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2008, 56 (08) : 975 - 984
  • [45] Institutional Review Board Barriers and Solutions Encountered in the Collaboration Among Pharmacists and Physicians to Improve Outcomes Now Study: A National Multicenter Practice-Based Implementation Trial
    MacLaughlin, Eric J.
    Ardery, Gail
    Jackson, Eric A.
    Ives, Timothy J.
    Young, Rodney B.
    Fike, David S.
    Carter, Barry L.
    PHARMACOTHERAPY, 2013, 33 (09): : 902 - 911
  • [46] Institutional review board barriers and solutions encountered in the collaboration among pharmacists and physicians to improve outcomes now study: a national multicenter practice-based implementation trial.
    MacLaughlin, Eric
    Ardery, Gail
    Jackson, Eric
    Ives, Timothy J.
    Young, Rodney B.
    Fike, David S.
    Carter, Barry
    PHARMACOTHERAPY, 2013, 33 (10): : E222 - E223
  • [47] Variation in standards of research compensation and child assent practices: A comparison of 69 institutional review board-approved informed permission and assent forms for 3 multicenter pediatric clinical trials
    Kimberly, MB
    Hoehn, KS
    Feudtner, C
    Nelson, RM
    Schreiner, M
    PEDIATRICS, 2006, 117 (05) : 1706 - 1711
  • [48] Design and implementation of community consultation for research conducted under exception from informed consent regulations for the PreVent and the PreVent 2 trials: Changes over time and during the COVID-19 pandemic
    Gugel, Tom
    Adams, Karen
    Baranoski, Madelon
    Yanez, N. David
    Kampp, Michael
    Johnson, Tesheia
    Aydin, Ani
    Fajardo, Elaine C.
    Sharp, Emily
    Potnis, Aartee
    Johnson, Chanel
    Treggiari, Miriam M.
    CLINICAL TRIALS, 2024,
  • [49] Degree of variability among institutional review boards (IRBs) on approved research practices and informed consent (IC) forms: A case study of a NIH-sponsored multi-center ARDS clinical trial
    Silverman, HJ
    Hull, SC
    Sugarman, J
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (03) : A916 - A916